Vascular targeting in ovarian cancer: Therapeutic advances may improve the prognosis
Targeting tumor vasculature by inhibiting angiogenesis is a promising approach for women with advanced ovarian cancer, and clinical trials should designed to ensure that novel agents are evaluated rapidly
